of the former compound to the skin of mice increased tumour incidence following twice-weekly applications of 0*3 per cent methylcholanthrene in benzene for 16 weeks.
These and a number of other quinones, and their substituted derivatives, were first tested for hyperplastic action on mouse epidermis (Table I) . Four selected members of the group, two hyperplastic and two non-hyperplastic, were then tested for co-carcinogenic action. Group 3: Hormones.
Testosterone has been shown to delay carcinogenesis by chemical carcinogens applied to the skin or injected subcutaneously. (Flaks and Ber, 1938a , 1938b Flaks, 1948) . Oestrone has been shown to increase the mitotic rate in epidermis (Bullough, 1950) . Oestradiol was tested for co-carcinogenic action.
Group 4: Miscellaneous -group of irritants, vesicants, and purgatives.
The following were also tested as co-carcinogens: Turpentine, an irritant for mouse skin (Berenblum, 1935 , Glicksmann, 1945 ) was shown to be co-carcinogenic for rabbit skin (Rous and Kidd, 1941) , but not for mouse skin (Shubik, 1950) .
Cantharidin, though strongly irritant for mouse skin, reduced the yield of tumours when applied alternately with tar (Berenblum, 1935) .
Mustard oil, an irritant and vesicant for human skin, was found by Visser and Ten Seldam (1938) to be non-carcinogenic, and without effect on tar carcinogenesis, in mouse skin.
Scarlet R was selected from a number of substances which have been shown to produce epithelial hyperplasia when injected subcutaneously (for review see Borst, 1924) .
Oleic acid was shown by Shubik (1950) to cause slight hyperplasia of mouse skin, but to have no co-carcinogenic action when applied after a single dose of a carcinogen. Twort and Twort (1939) , however, showed that it augmented carcinogenic action of a small dose of 3: 4 benzpyrene.
Podophyllin resin was selected from a number of strong purgatives because it was found to have a hyperplastic action on mouse skin. It also produces mitotic 483 abnormalities (King and Cauldwell, 1949) Berenblum (1951) found it noncarcinogenic when applied alone to mouse skin, and slightly anti-carcinogenic when applied alternately with benzpyrene. Other purgatives (jalap, colocynth, aloes, scammony, and guiacum) had no appreciable hyperplastic effect on mouse epidermis, and were not further tested.
METHODS.
Mice.-Stock albinos of the " S " strain (Salaman and Gwynn, 1951) were used. They were fed on rat cubes made according to the Rowett Institute formula (Thomson, 1930) , and water ad libitum.
Primary treatment.-An initial application of 0 3 ml. of 0-1 or 0-15 per cent 9: 10 dimethyl-I 2 benzanthracene (DMBA) in acetone was made to the whole back, after the hair had been clipped
Interval.-Before further treatment a period varying between 21 and 39 days was allowed to elapse. The exact length of this interval, in view of Berenblum's results with croton oil (Berenblum and Shubik, 1949b), was not considered to be critical.
Secondary treatment.-Substances to be tested for co-carcinogenic action were dissolved in acetone in concentrations found, in preliminary tests, to be the maximum tolerated without severe crusting or ulceration. Weekly, or occasionally twice a week, 0.3 ml. amounts of these solutions were applied to the previously treated areas.
In a few cases the concentration and frequency of these applications had to be varied during the course of the experiment, owing to the development of excessive crusting, as recorded below. Acetone (AR grade) was the solvent throughout, but in the case of Scarlet R, 10 per cent liquid paraffin, and in that of oestradiol, 10 per cent arachis oil, was added. These treatments were continued for periods varying from 140 to 200 days. They are recorded in Table II . Biopsies.-Pieces of skin, approximately 1 X 0 5 cm. in area, were removed under ether anaesthesia from the treated areas at intervals during the secondary treatments. Tissues were fixed in Zenkers fluid, and stained with haematoxylin and Eosin-Biebrich Scarlet [Eosin (water soluble) and Biebrich Scarlet each 0'5 g., glycerol 10 ml., methanol 40 ml., distilled water 450 ml.]
Tumour incidence.-Tumours were recorded weekly, and a final count made 3 days after the last treatment. They were observed visually for signs of malignancy, and sections were cut, after autopsy, in suspicious cases.
RESULTS.
In general, 5-10 days after the primary painting with the carcinogen most mice showed some degree of epilation. About a third developed a mild degree of scabbing, or firm raised ridges or lumps of thickened skin, ususally in the scapular region, 10 to 15 X 2 to 3 mm. in area; most of these were visible for only 2 to 3 weeks, though a few gave rise to tumours later. By the time secondary treatment was started the hair had grown, and there were only a small number of persistent thickenings and scars visible. Very little further epilation or crusting occurred during the secondary treatments, except in the cases of iodoacetic acid, chloroacetophenone, cantharidin, and podophyllin.
Tumour incidence.
All tumours appeared to be benign papillomas macroscopically, of diameters 1 to 10 mm. No evidence of malignancy was found in the few suspicious tumours examined microscopically. Subsequent observation in this laboratory has shown (unpublished results) that a much longer time must elapse before an appreciable number of malignant tumours are seen after a small dose of a carcinogen followed by repeated treatment with a co-carcinogen.
A few tumours appeared in the control groups (1 and 2, no secondary treatment): 4 among 21 survivng mice; and only one tumour among 12 surviving mice in Group 3 (acetone as secondary treatment).
In Groups 4 and 5 (croton oil as secondary treatment) there were 215 tumours on 17 surviving mice: many more were seen at an earlier date, but a number of mice bearing large numbers of tumours died before the end of the experiment.
Among the remaining groups, only in 6 and 7 (iodoacetic acid and chloroacetophenone as secondary treatments, respectively), was the tumour incidence significantly greater than that in the control group. The 10 surviving mice of Group 6 carried between them 54 tumours, while the 12 survivors of Group 7 carried 10 tumours between them, at the end of the experiment.
In Group 17 (1: 4 naphthoquinone), 19 (2 methyl 1: 4 naphthoquinone), 8 (iodoacetamide) and 11 (Scarlet R), the tumour incidence was slightly higher than that of the controls, but these results are not statistically significant.
Details of these results are found in Table II , and the course of tumour appearance for Groups 1, 4, 6, 7, and 19 , expressed as the mean number of tumours per surviving mouse plotted against time, in Fig. 1 .
By comparing these means at 15 and 22 weeks after the start of secondary treatments it was shown that tumour incidences in Groups 4, 6, and 7 are significantly higher than in Group 1 (controls,) and also different from each other, whereas the incidence in Group 19 is not significantly different from that of the : 2-methyl 1:4-naphthoquinone).
All groups received one primary treatment with 9:10 dimethyl 1:2 benzanthracene 3 to 6 weeks before the beginning of secondary treatments.
controls, though the figures suggest that such a difference might have been observed in a larger experiment.
Histology.
All those substances which were definitely co-carcinogenic caused marked epidermal hyperplasia, but hyperplasia was also caused by substances that were not co-carcinogenic. A measure of the hyperplasia was obtained by counting the total number of cells per 1 mm. length of epidermis, excluding hair follicles.
In addition the percentage of " resting cells", i.e. basal cells proper (Glucksman 1945) , in the epidermis of mice in 8 of the groups was determined by methods previously described (Salaman and Gwynn, 1951) . A single count was made on the epidermis of mice taken from the selected groups, at about the time that tumours were beginning to appear in the croton oil-treated animals (59-66 days after the start of secondary treatment). Of the groups selected three had been treated with substances that produced both epidermal hyperplasia and tumours (croton oil, iodoacetic acid, and chloroacetophenone), and four with substances that caused epidermal hyperplasia but no tumours (iodoacetamide, oleic acid, Scarlet R, and mustard oil). The last substance caused only a weak hyperplasia.
The percentage of resting cells was significantly raised above that of the control group (1) in the chloroacetophenone and iodoacetic acid groups (6 and 7); as well as in the croton oil group (4) (as previously reported, Salaman and Gwynn, 1951), but not in any of the other groups.
The total number of cells per mm. of epidermis was significantly higher than in the control in all the selected groups, except that treated with mustard oil, and highest in the croton oil group. Total and resting cell counts are given in Table III. DISCUSSION.
Of the substances tested, iodoacetic acid and chloroacetophenone were found to possess marked co-carcinogenic power, though in the concentrations used this was inferior to that of croton oil. 2-Methyl-1: 4 naphthoquinone slightly increased tumour incidence compared with controls; this result is suggestive but, under the conditions of this experiment, it cannot be shown to be statistically significant. The effects produced by iodoacetamide, 1: 4 naphthoquinone, and Scarlet R were even less definite. The other substances were inactive. . 15-8±08 . 202± 5-8 All groups received one primary treatment with 9:10 dimethyl 1:2 benzanthracene 3 to 6 weeks before the beginning of secondary treatments.
From Table III it is evident that iodoacetic acid, chloroacetophenone, and croton oil (the co-carcinogenic substances) increase the percentage of resting cells in mouse epidermis previously treated with a carcinogen, while the non-co-carcinogenic substances tested do not. This suggests a connection between the two properties. The significance of such a connection is at present quite unknown.
Epidermal hyperplasia, however, measured as the increase in total number of cells per mm. length of epidermis, is not significantly greater in the co-carcinogenic than in the non-co-carcinogenic groups. Hyperplasia may be a necessary, but is not a sufficient, condition for co-carcinogenic action. It is evident too, that the purgative or vesicant properties of the agents tested are not associated with co-carcinogenicity.
The occurence of two co-carcinogenic substances among the three -SH reactors tested is interesting. It has been suggested that carcinogens themselves may react with -SH groups (Crabtree, 1945 (Crabtree, , 1947 Calcutt, 1949) . Crabtree (1940) found that a number of -SH reactors retarded tumour formation when applied alternatively with a carcinogenic hydrocarbon to mouse skin, but that one of them, chloracetone (Crabtree, 1941) slightly stimulated tumour formation when applied after a course of treatment with benzpyrene. The failure of iodoacetamide to produce tumours may have been due to faulty penetration or rapid removal. It is clear that so little is known of the effective concentration at susceptible sites in a tissue of applied substances of varying physical properties that it is not profitable to attempt to correlate observed co-carcinogenic potency with other chemical activity.
SUMMARY.
